Prosecution Insights
Last updated: October 25, 2026
Application No. 18/410,623

SYSTEM AND METHOD FOR DETECTING PRESENCE OF AN INFUSION CARTRIDGE IN AN INFUSION PUMP

Non-Final OA §102§103
Filed
Jan 11, 2024
Priority
Mar 15, 2013 — continuation of 13/837,661 +1 more
Examiner
FREHE, WILLIAM R
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Tandem Diabetes Care Inc.
OA Round
1 (Non-Final)
60%
Grant Probability
Moderate
1-2
OA Rounds
12m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 60% of resolved cases
60%
Career Allowance Rate
236 granted / 395 resolved
-10.3% vs TC avg
Strong +42% interview lift
Without
With
+42.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
43 currently pending
Career history
456
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
54.7%
+14.7% vs TC avg
§102
13.8%
-26.2% vs TC avg
§112
25.9%
-14.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 395 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Election/Restrictions Applicant’s election without traverse of Group I in the reply filed on 09/16/2026 is acknowledged. In the present case, all claims are directed to Group I and thus, no claims are withdrawn. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (b) the invention was patented or described in a printed publication in this or a foreign country or in public use or on sale in this country, more than one year prior to the date of application for patent in the United States. Claims 20-29 are rejected under pre-AIA 35 U.S.C. 102(b) as being anticipated by Alderete et al. (USPGPub 2012/0259282). Re Claim 20, Alderete teaches an ambulatory infusion pump system (100), comprising: an infusion cartridge (111) including a reservoir configured to contain a medicament (Alderete Figs. 2-3; ¶ 0065-0066); an infusion pump configured to selectively receive the infusion cartridge (111) (Alderete Figs. 2-3; ¶ 0065-0066), the infusion pump including a pump motor (124) configured to operate a drive mechanism (125) to cause medicament from the infusion cartridge (111) to be delivered to a user (Alderete ¶ 0070-0071); and at least one processor (122) configured to: execute a closed loop motor control algorithm configured to generate pulse width modulation (PWM) commands as electrical command input into the pump motor to operate the drive mechanism; control a velocity output of the pump motor with the PWM commands such that a value of the PWM commands is proportional to a load on the pump motor (Alderete ¶ 0220, 0215-0259); compare values of the PWM commands to a threshold value (Alderete ¶ 0217-0259); and generate a missing cartridge indication if the values of the PWM commands drop below the threshold value by a predetermined amount (Alderete ¶ 0238). Re Claim 21, Alderete teaches wherein the threshold value is determined based off of PWM commands applied to the pump motor during a loading sequence of the infusion cartridge onto the infusion pump (Alderete ¶ 0244, 0215-0259). Re Claim 22, Alderete teaches wherein the PWM commands are uniform amplitude voltage pulses (Alderete ¶ 0076). Re Claim 23, Alderete teaches wherein the predetermined amount is based on a pumping speed of pump operations (Alderete ¶ 0013-0017; 0230-0242 – teaching encoder counts). Re Claim 24, Alderete teaches wherein the predetermined amount is lower for lower pumping speeds and higher for higher pumping speeds (Alderete ¶ 0230-0242). Re Claim 25, Alderete teaches the infusion pump system further comprising a user interface (104, 106) configured to display the missing cartridge indication (Alderete ¶ 0062, 0082-0083, 0094, 0238). Re Claim 26, Alderete teaches wherein the user interface (104, 106) is part of the infusion pump (100) (as seen in Alderete Fig. 1). Re Claim 27, Alderete teaches wherein the value of each of the PWM commands is a duty cycle of a series of electrical pulses provided as input to power the pump motor for each motor move of a pumping cycle (Alderete ¶ 0155, 0198-0204). Re Claim 28, Alderete teaches wherein the value of each PWM command is a unitless number (Alderete ¶ 0155, 0198-0204). Re Claim 29, Alderete teaches wherein the unitless number is a percentage (Alderete ¶ 0155, 0198-0204). Claim Rejections - 35 USC § 103 The following is a quotation of pre-AIA 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action: (a) A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 30-39 are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Alderete et al. (USPGPub 2012/0259282) in view of Bazargan et al. (USPGPub 2010/0164727). Re Claim 30, Alderete teaches an ambulatory infusion pump system (100), comprising: an infusion cartridge (111) including a reservoir configured to contain a medicament (Alderete Figs. 2-3; ¶ 0065-0066); an infusion pump configured to selectively receive the infusion cartridge (111) (Alderete Figs. 2-3; ¶ 0065-0066), the infusion pump including a pump motor (124) configured to operate a drive mechanism (125) to cause medicament from the infusion cartridge (111) to be delivered to a user (Alderete ¶ 0070-0071), and at least one processor (122) configured to: generate operational pulse width modulation (PWM) commands as electrical command input into the pump motor (124) causing the pump motor to operate the drive mechanism; control a velocity output of the pump motor with a velocity loop algorithm by generating the operational PWM commands as electrical command input into the pump motor (Alderete ¶ 0220, 0215-0259); compare values of the operational PWM commands that are generated as electrical command input into the pump motor during pumping operations to a threshold value of PWM commands (Alderete ¶ 0217-0259); and generate a cartridge indication if the values of the operational PWM commands drop below the threshold value of PWM commands by a predetermined amount (Alderete ¶ 0238). Alderete fails to explicitly disclose the generation of the cartridge indication being a missing cartridge indication. Bazargan discloses a system for detecting the presence of a cartridge comprising initiating a safety check to inform a user of a missing cartridge and prompt the user to insert a cartridge, or otherwise investigate the reason for why no cartridge is detected, thus improving the safety of the device (Bazargan ¶ 0059-0060). Therefore, it would have been obvious to one of ordinary skill in the art at the time of the invention to have configured the cartridge indication of Alderete to be a missing cartridge indication as disclosed by Bazargan wherein the indication can prompt a user to insert a cartridge, or otherwise investigate the reason for why no cartridge is detected, thus improving the safety of the device (Bazargan ¶ 0059-0060). Re Claim 31, Alderete in view of Bazargan teach all of the limitations of Claim 30. Alderete teaches wherein the at least one processor is further configured to: initiate an infusion cartridge loading sequence when the infusion cartridge is loaded onto the infusion pump (Alderete ¶ 0214-0215); record loading PWM commands applied to the pump motor during the loading sequence (Alderete ¶ 0215-0216), and wherein the threshold value is determined based off of the loading PWM commands (Alderete ¶ 0244, 0215-0259). Re Claim 32, Alderete in view of Bazargan teach all of the limitations of Claim 30. Alderete teaches wherein the PWM commands are uniform amplitude voltage pulses (Alderete ¶ 0076). Re Claim 33, Alderete in view of Bazargan teach all of the limitations of Claim 30. Alderete teaches wherein the predetermined amount is based on a pumping speed of pump operations (Alderete ¶ 0013-0017; 0230-0242 - encoder counts). Re Claim 34, Alderete in view of Bazargan teach all of the limitations of Claim 33. Alderete teaches wherein the predetermined amount is lower for lower pumping speeds and higher for higher pumping speeds (Alderete ¶ 0230-0242). Re Claim 35, Alderete in view of Bazargan teach all of the limitations of Claim 30. Alderete teaches wherein generating a cartridge indication includes displaying the cartridge indication on a user interface (104, 106) of the infusion pump system (Alderete Fig. 1; ¶ 0238). However, Alderete fails to explicitly teach wherein generating a missing cartridge indication includes displaying the missing cartridge indication on a user interface of the infusion pump system. Bazargan discloses generating a missing cartridge indication includes displaying the missing cartridge indication on a user interface of the infusion pump system as a safety check to inform a user of a missing cartridge and prompt the user to insert a cartridge, or otherwise investigate the reason for why no cartridge is detected, thus improving the safety of the device (Bazargan ¶ 0059-0060). Therefore, it would have been obvious to one of ordinary skill in the art at the time of the invention to have configured the cartridge indication of Alderete in view of Bazargan wherein generating a missing cartridge indication includes displaying the missing cartridge indication on a user interface of the infusion pump system as disclosed by Bazargan wherein the indication can prompt a user to insert a cartridge, or otherwise investigate the reason for why no cartridge is detected, thus improving the safety of the device (Bazargan ¶ 0059-0060). Re Claim 36, Alderete in view of Bazargan teach all of the limitations of Claim 35. Alderete teaches wherein the user interface (104, 106) is part of the infusion pump (100) (as seen in Alderete Fig. 1). Re Claim 37, Alderete in view of Bazargan teach all of the limitations of Claim 30. Alderete teaches wherein the value of each of the PWM commands is a duty cycle of a series of electrical pulses provided as input to power the pump motor for each motor move of a pumping cycle (Alderete ¶ 0155, 0198-0204). Re Claim 38, Alderete in view of Bazargan teach all of the limitations of Claim 30. Alderete teaches wherein the value of each PWM command is a unitless number (Alderete ¶ 0155, 0198-0204). Re Claim 39, Alderete in view of Bazargan teach all of the limitations of Claim 38. Alderete teaches wherein the unitless number is a percentage (Alderete ¶ 0155, 0198-0204). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to WILLIAM R FREHE whose telephone number is (571)272-8225. The examiner can normally be reached 10:30AM-7:30PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Sirmons can be reached at 571-272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WILLIAM R FREHE/Examiner, Art Unit 3783 /KEVIN C SIRMONS/Supervisory Patent Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Jan 11, 2024
Application Filed
Oct 16, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746333
MULTI-COMPARTMENT SYRINGE WITH PUMP MECHANISM
6y 1m to grant Granted Sep 29, 2026
Patent 12706208
SENSOR NETWORK FOR BREAST PUMPING MOTHERS
5y 10m to grant Granted Aug 11, 2026
Patent 12691221
DISCRETIONARY INSULIN DELIVERY SYSTEMS AND METHODS
6y 5m to grant Granted Jul 28, 2026
Patent 12667524
NASOGASTRIC TUBE
5y 4m to grant Granted Jun 30, 2026
Patent 12667650
A BREAST MILK EXTRACTION KIT COMPRISING A BREAST MILK PUMP AND A PUMPING DEVICE
3y 5m to grant Granted Jun 30, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
60%
Grant Probability
99%
With Interview (+42.2%)
3y 9m (~12m remaining)
Median Time to Grant
Low
PTA Risk
Based on 395 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month